AmgenThousand Oaks, CA, United States
Clinical Pharmacologist in Pharmacutical Industry since 1999
2161: Pharmacokinetic and Safety Similarity of High- and Low-Concentration Formulations of Adalimumab Biosimilar ABP 501
Tuesday, November 14, 20239:00 AM – 11:00 AM PT
Disclosure information not submitted.